The Agency for Healthcare Research and Quality this week named as its new director Robert “Bob” Otto Valdez, Robert Wood Johnson Foundation professor emeritus of family and community medicine and economics at the University of New Mexico. David Meyers, M.D., who served as acting director since 2021 and has resumed his role as deputy director, said Valdez “is taking the helm at an opportune time as we look to the future of healthcare post-COVID and set our sights on how we can improve care, including health equity.” 

Related News Articles

Headline
Rural hospital leaders recently shared strategies and insights on improving safety culture, governance and care reliability at the AHA’s Rural Patient Safety…
Headline
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier…
Headline
The Senate Finance Committee Oct. 29 held a hearing on the nominations of Thomas March Bell to be inspector general of the Department of Health and Human…
Blog
Public
Cross-industry insights and new technology are helping HCA Healthcare reduce risk, improve outcomes and lead the future of high-reliability careFor Randy Fagin…
Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…
Headline
The AHA is seeking speakers for the 2026 AHA Leadership Summit who can share strategies, case examples and lessons learned that demonstrate how hospitals and…